Connect with us

Hi, what are you looking for?

Jewish Business News


Ocado CEO Tim Steiner Is Not Worried That Partner Morrisons Pushed Out Boss



Although Morrisons, an Bradford, England based supermarket group, kicked out its CEO Dalton Phillips, Tim Steiner, CEO of its long-term partner, delivery company Ocado, is not concerned, and feels the deal is rock solid. Morrisons agreed to a 25 year deal with Ocado, which thanks to the strength of holiday sales, posted its first post-tax profit since the company was founded in 2000. Duncan Tatton-Brown, finance director of Ocado told the Daily Telegraph, “It is not something we would expect, and we’re protected by the contract, anyway.”

Tim Steiner said, “Our focus remained on delivering the highest service level at this very important time for customers, while offering the widest range at competitive prices.” Ocado reported a 14.8% increase in December sales with 40% more items for both Morrison’s and Ocado than the same period in 2013.

While the deal with Morrisons may seem secure, the partnership with Waitrose may be more shaky, as Waitrose can pull out of the deal in September, if it so chooses. It is possible that Waitrose may chose to fly solo and run its own grocery delivery operations. In addition, Ocado could face some heat from low cost competitors, as the supermarket industry in Britain facing cutthroat competition, with prices slashed dramatically.


master.Dundee_7 Morrisons

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


Now Platika joins and elite club of $10 billion plus Israeli firms.